JUBILANT PHARMOVA LTD (JUBLPHARMA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.[1]
Jubilant Pharmova Ltd
JUBLPHARMA
ROE1.35%
ROCE1.80%
Stock P/E520
Book Value₹145
Face Value₹1.00
High / Low₹1,250/784
Market Cap₹16,300Cr.
Current Price₹1,023
Dividend Yield0.49%
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 17 July 2026 at 19:05:26